Cargando…

Towards a subsiding diabetes epidemic: trends from a large population-based study in Israel

BACKGROUND: With increasing diabetes prevalence worldwide, an impending diabetes “pandemic” has been reported. However, definitions of incident cases and the population at risk remain varied and ambiguous. This study analyzed trends in mortality and screening that contribute to diabetes prevalence a...

Descripción completa

Detalles Bibliográficos
Autores principales: Karpati, Tomas, Cohen-Stavi, Chandra J, Leibowitz, Morton, Hoshen, Moshe, Feldman, Becca S, Balicer, Ran D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233034/
https://www.ncbi.nlm.nih.gov/pubmed/25400512
http://dx.doi.org/10.1186/s12963-014-0032-y
_version_ 1782344674293317632
author Karpati, Tomas
Cohen-Stavi, Chandra J
Leibowitz, Morton
Hoshen, Moshe
Feldman, Becca S
Balicer, Ran D
author_facet Karpati, Tomas
Cohen-Stavi, Chandra J
Leibowitz, Morton
Hoshen, Moshe
Feldman, Becca S
Balicer, Ran D
author_sort Karpati, Tomas
collection PubMed
description BACKGROUND: With increasing diabetes prevalence worldwide, an impending diabetes “pandemic” has been reported. However, definitions of incident cases and the population at risk remain varied and ambiguous. This study analyzed trends in mortality and screening that contribute to diabetes prevalence and incidence, distinguishing between new incident cases and newly detected cases. METHODS: In an integrated provider-and-payer-system covering 53% of Israel’s population, a composite diabetes case-finding algorithm was built using diagnoses, lab tests, and antidiabetic medication purchases from the organization’s electronic medical record database. Data were extracted on adult members aged 26+ each year from January 1, 2004 through December 31, 2012. Rates of diabetes prevalence, incidence, screening, and mortality were reported, with incidence rates evaluated among the total, “previously-screened,” and “previously-unscreened” at-risk populations. RESULTS: There were 343,554 diabetes cases in 2012 (14.4%) out of 2,379,712 members aged 26+. A consistent but decelerating upward trend in diabetes prevalence was observed from 2004–2012. Annual mortality rates among diabetics decreased from 13.8/1000 to 10.7/1000 (p = 0.0002). Total population incidence rates declined from 13.3/1000 in 2006 to 10.8/1000 in 2012 (p < 0.0001), with similar incidence trends (13.2/1000 to 10.2/1000; p = 0.0007) among previously-screened at-risk members, and a rise in testing rates from 53.0% to 66.7% (p = 0.0004). The previously-unscreened group decreased 28.6%, and the incidence rates within this group remained stable. CONCLUSIONS: The increase in diabetes prevalence is decelerating despite declining mortality and increasing testing rates. A decline in previously-screened incident cases and a shrinking pool of previously-unscreened members suggests that diabetes trends in Israel are moving toward equilibrium, rather than a growing epidemic. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12963-014-0032-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4233034
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42330342014-11-17 Towards a subsiding diabetes epidemic: trends from a large population-based study in Israel Karpati, Tomas Cohen-Stavi, Chandra J Leibowitz, Morton Hoshen, Moshe Feldman, Becca S Balicer, Ran D Popul Health Metr Research BACKGROUND: With increasing diabetes prevalence worldwide, an impending diabetes “pandemic” has been reported. However, definitions of incident cases and the population at risk remain varied and ambiguous. This study analyzed trends in mortality and screening that contribute to diabetes prevalence and incidence, distinguishing between new incident cases and newly detected cases. METHODS: In an integrated provider-and-payer-system covering 53% of Israel’s population, a composite diabetes case-finding algorithm was built using diagnoses, lab tests, and antidiabetic medication purchases from the organization’s electronic medical record database. Data were extracted on adult members aged 26+ each year from January 1, 2004 through December 31, 2012. Rates of diabetes prevalence, incidence, screening, and mortality were reported, with incidence rates evaluated among the total, “previously-screened,” and “previously-unscreened” at-risk populations. RESULTS: There were 343,554 diabetes cases in 2012 (14.4%) out of 2,379,712 members aged 26+. A consistent but decelerating upward trend in diabetes prevalence was observed from 2004–2012. Annual mortality rates among diabetics decreased from 13.8/1000 to 10.7/1000 (p = 0.0002). Total population incidence rates declined from 13.3/1000 in 2006 to 10.8/1000 in 2012 (p < 0.0001), with similar incidence trends (13.2/1000 to 10.2/1000; p = 0.0007) among previously-screened at-risk members, and a rise in testing rates from 53.0% to 66.7% (p = 0.0004). The previously-unscreened group decreased 28.6%, and the incidence rates within this group remained stable. CONCLUSIONS: The increase in diabetes prevalence is decelerating despite declining mortality and increasing testing rates. A decline in previously-screened incident cases and a shrinking pool of previously-unscreened members suggests that diabetes trends in Israel are moving toward equilibrium, rather than a growing epidemic. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12963-014-0032-y) contains supplementary material, which is available to authorized users. BioMed Central 2014-10-30 /pmc/articles/PMC4233034/ /pubmed/25400512 http://dx.doi.org/10.1186/s12963-014-0032-y Text en © Karpati et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Karpati, Tomas
Cohen-Stavi, Chandra J
Leibowitz, Morton
Hoshen, Moshe
Feldman, Becca S
Balicer, Ran D
Towards a subsiding diabetes epidemic: trends from a large population-based study in Israel
title Towards a subsiding diabetes epidemic: trends from a large population-based study in Israel
title_full Towards a subsiding diabetes epidemic: trends from a large population-based study in Israel
title_fullStr Towards a subsiding diabetes epidemic: trends from a large population-based study in Israel
title_full_unstemmed Towards a subsiding diabetes epidemic: trends from a large population-based study in Israel
title_short Towards a subsiding diabetes epidemic: trends from a large population-based study in Israel
title_sort towards a subsiding diabetes epidemic: trends from a large population-based study in israel
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233034/
https://www.ncbi.nlm.nih.gov/pubmed/25400512
http://dx.doi.org/10.1186/s12963-014-0032-y
work_keys_str_mv AT karpatitomas towardsasubsidingdiabetesepidemictrendsfromalargepopulationbasedstudyinisrael
AT cohenstavichandraj towardsasubsidingdiabetesepidemictrendsfromalargepopulationbasedstudyinisrael
AT leibowitzmorton towardsasubsidingdiabetesepidemictrendsfromalargepopulationbasedstudyinisrael
AT hoshenmoshe towardsasubsidingdiabetesepidemictrendsfromalargepopulationbasedstudyinisrael
AT feldmanbeccas towardsasubsidingdiabetesepidemictrendsfromalargepopulationbasedstudyinisrael
AT balicerrand towardsasubsidingdiabetesepidemictrendsfromalargepopulationbasedstudyinisrael